AbbVie wins EU approval for paediatric pJIA use
New indication adds oral option for young patients
Read More
Author: John Pinching
Investor horizons ahead of CPHI 2026
Key CDMO trends shaping strategies in a shifting global market
Read More
Lexeo expands Friedreich ataxia pipeline with Mantle deal
Acquisition adds new frataxin‑targeted modalities
Read More
AC immune reports week-100 progress in VacSyn trial
Phase 2 data show strong safety and immunogenicity
Read More
Carvykti delivers five-year remissions in early myeloma
Half of patients remained progression-free without maintenance
Read More
